1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Arthritis, Rheumatoid in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 14 (66.67) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Q; Du, Y; Wu, H | 1 |
| Fang, L; Liu, J; Tan, B; Zhang, P; Zhu, F | 1 |
| Jancar, S; Ribeiro-Dias, F; Shio, MT; Timenetsky, J | 1 |
| Hikiji, H; Ishii, S; Shimizu, T; Takato, T | 1 |
| Brown, KA; Crawford, N; Eggleton, P; Penhallow, J; Wang, L | 1 |
| Aissa, J; Benveniste, J; Hilliquin, P; Houbaba, H; Menkes, CJ | 1 |
| Arnoux, A; Dulioust, A; Gregoir, C; Hilliquin, P; Menkés, CJ | 1 |
| Battaglia, E; Camussi, G; Lupia, E; Modena, V; Montrucchio, G | 1 |
| Gawdi, G; Gonzalez-Gronow, M; Misra, UK; Pizzo, SV | 1 |
| Chermat-Izard, V; Hilliquin, P; Menkes, CJ | 1 |
| Blackburn, WD; Chatham, WW; Heck, LW | 2 |
| Arnoux, B; Benveniste, J; Hilliquin, P; Laoussadi, S; Menkes, CJ | 1 |
| Johnson, JA; Smith, DM; Turner, RA | 1 |
| Chang, FY; Chang, ML; Chou, CT; Shaio, MF | 1 |
| Sharma, JN | 1 |
| Sperling, RI | 1 |
| Austen, KF; Benincaso, AI; Coblyn, JS; Larkin, JK; Sperling, RI; Weinblatt, ME | 1 |
| Niwa, Y; Ohashi, T; Ozaki, Y | 1 |
| Henderson, B; Higgs, GA; Pettipher, ER | 1 |
| Coblyn, JS; Fraser, PA; Hoover, RL; House, F; Ravalese, J; Robin, JL; Robinson, DR; Sperling, RI; Spur, BW; Weinblatt, M | 1 |
4 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
The roles of small-molecule inflammatory mediators in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Inflammation; Inflammation Mediators; Interleukin-1alpha; Interleukin-6; Leukotrienes; Lipoxins; Nitric Oxide; Platelet Activating Factor; Prostaglandins; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2021 |
The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease.
Topics: Animals; Arthritis, Rheumatoid; Bone and Bones; Bone Diseases; Cell Differentiation; Dogs; Extracellular Matrix; Fractures, Bone; Humans; Interleukins; Leukotrienes; Mice; Osteoblasts; Peptide Hydrolases; Periodontitis; Platelet Activating Factor; Prostaglandins; RANK Ligand; Rats; Receptors, Prostaglandin E | 2008 |
Pro-inflammatory actions of the platelet activating factor: relevance to rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Humans; Inflammation; Platelet Activating Factor; Rabbits; Rats | 1991 |
Dietary omega-3 fatty acids: effects on lipid mediators of inflammation and rheumatoid arthritis.
Topics: Arachidonate 5-Lipoxygenase; Arthritis, Rheumatoid; Dietary Fats; Fatty Acids, Omega-3; Humans; Inflammation; Lipids; Platelet Activating Factor | 1991 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
A double blind, placebo controlled study of a platelet activating factor antagonist in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Azepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Activating Factor; Platelet Aggregation Inhibitors; Thienopyridines; Treatment Outcome; Triazoles | 1998 |
Biochemical perturbations of BW 91Y (3-deazaadenosine) on human neutrophil chemotactic potential and lipid metabolism.
Topics: Arachidonic Acids; Arthritis, Rheumatoid; Calcimycin; Chemotaxis, Leukocyte; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Leukotriene B4; Lipid Metabolism; Lipids; Neutrophils; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Platelet Activating Factor; Tubercidin | 1991 |
15 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
[Hypercoagulable state is associated with NF-kappa B activation and increased inflammatory factors in patients with rheumatoid arthritis].
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Blood Coagulation; Blood Coagulation Tests; Blotting, Western; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; NF-kappa B; Platelet Activating Factor; Platelet Count; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor Receptor-Associated Peptides and Proteins; Young Adult | 2016 |
PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells.
Topics: Animals; Antigens; Antigens, Bacterial; Arthritis, Rheumatoid; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Enzyme Inhibitors; Isoenzymes; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C3H; Mitogens; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peritoneum; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Proteins; Signal Transduction; Superantigens; Up-Regulation | 2004 |
Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cell Separation; Electrophoresis; Humans; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Respiratory Burst; Superoxides; Synovial Fluid | 1995 |
Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis. Influence of parenteral corticosteroids.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Female; Humans; Middle Aged; Phospholipases A; Platelet Activating Factor; Synovial Fluid; Tumor Necrosis Factor-alpha | 1995 |
Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Calcimycin; Humans; In Vitro Techniques; Ionophores; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Synovial Fluid | 1995 |
Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Collagen; Disease Models, Animal; Drug Combinations; Female; Humans; Laminin; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neovascularization, Pathologic; Osteoarthritis; Platelet Activating Factor; Proteoglycans; Synovial Fluid; Tumor Necrosis Factor-alpha | 1996 |
Up-regulation of the alpha2-macroglobulin signaling receptor on rheumatoid synovial fibroblasts.
Topics: alpha-Macroglobulins; Arthritis, Rheumatoid; Calcium; Cell Division; Cells, Cultured; Fibroblasts; Humans; Inositol 1,4,5-Trisphosphate; Low Density Lipoprotein Receptor-Related Protein-1; Platelet Activating Factor; Receptors, Immunologic; Signal Transduction; Synovial Membrane; Up-Regulation | 1997 |
Ligand dependent release of activated neutrophil collagenase--a role for surface bound IgG in the degradation of articular collagens.
Topics: Arthritis, Rheumatoid; Cartilage, Articular; Collagenases; Humans; Immunoglobulin G; Ligands; Matrix Metalloproteinase 8; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Receptors, Antigen, B-Cell; Synovial Fluid; Tetradecanoylphorbol Acetate; Zymosan | 1992 |
Presence of paf-acether in rheumatic diseases.
Topics: Arthritis, Rheumatoid; Chondrocalcinosis; Humans; Lipoproteins; Platelet Activating Factor; Rheumatic Diseases; Synovial Fluid | 1992 |
Neutrophil chemiluminescence and superoxide production in patients with rheumatoid arthritis: the effect of zymosan, phorbol myristate acetate and platelet-activating factor.
Topics: Arthritis, Rheumatoid; Humans; Luminescent Measurements; Neutrophils; Platelet Activating Factor; Superoxides; Synovial Fluid; Tetradecanoylphorbol Acetate; Zymosan | 1991 |
Ligand-dependent release of active neutrophil collagenase.
Topics: Arthritis, Rheumatoid; Cartilage, Articular; Humans; Immunoglobulin G; In Vitro Techniques; Ligands; Microbial Collagenase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Radioimmunoassay; Zymosan | 1990 |
Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate.
Topics: Aged; Arachidonic Acid; Arachidonic Acids; Arthritis, Rheumatoid; Calcimycin; Chemotaxis, Leukocyte; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Methotrexate; Middle Aged; Neutrophils; Phospholipases; Platelet Activating Factor | 1990 |
Oxygen radical production by neutrophils from patients with bacterial infection and rheumatoid arthritis. Measurement of hydrogen peroxide may most accurately represent enhancement of oxygen radical production during infection.
Topics: Arthritis, Rheumatoid; Bacterial Infections; C-Reactive Protein; Calcimycin; Cytochalasin B; Free Radicals; Humans; Hydrogen Peroxide; Leukocyte Count; Neutrophils; Oxygen; Platelet Activating Factor; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1986 |
PAF-acether in chronic arthritis.
Topics: Animals; Arthritis; Arthritis, Rheumatoid; Chronic Disease; Disease Models, Animal; Humans; Inflammation; Injections, Intra-Articular; Male; Ovalbumin; Platelet Activating Factor; Rabbits; Synovial Fluid | 1987 |
Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis.
Topics: Adult; Arachidonate 5-Lipoxygenase; Arthritis, Rheumatoid; Chemotaxis, Leukocyte; Chronic Disease; Female; Fish Oils; Food, Fortified; Humans; Leukocytes; Lipids; Male; Middle Aged; Monocytes; Neutrophils; Platelet Activating Factor; Time Factors | 1987 |